NEW MOVIE OUT ABOUT mRNA VACCINES

Pascal Najadi Vaccine Hazard Activist Accomplishments.

Pascal Najadi has initiated several high-profile legal actions related to COVID-19 policies and vaccine mandates:
1. Criminal Complaint Against Swiss President Alain Berset: In December 2022, Najadi filed a criminal complaint against Swiss President Alain Berset, alleging abuse of public office under Article 310 of the Swiss Criminal Code. He accused Berset of making misleading public statements about the effectiveness of COVID-19 vaccines, particularly asserting that vaccinated individuals were not contagious, despite evidence to the contrary from the Federal Office of Public Health. This complaint led to the Swiss Attorney General launching an investigation into President Berset’s conduct—the first such case against a sitting Swiss head of state.
2. Civil Lawsuit Against Pfizer in New York: In March 2023, Najadi, alongside co-plaintiff Ana McCarthy, filed a civil lawsuit against Pfizer Inc. in the Supreme Court of the State of New York. The suit alleges that Pfizer made false claims regarding the safety and efficacy of its COVID-19 mRNA vaccine, leading to widespread harm. The plaintiffs argue that Pfizer violated state and federal laws by promoting the vaccine without adequate informed consent and transparency.
3. Legal Actions Involving the World Health Organization (WHO): In February 2023, Najadi led a team that served an emergency injunction and tribunal order to the WHO and other global entities. The order accused these organizations of participating in a criminal conspiracy to commit war crimes and crimes against humanity related to the COVID-19 pandemic response. The legal action invoked various international laws, including the Universal Declaration of Human Rights, and called for immediate cessation of alleged unlawful activities.

These legal actions reflect Najadi’s efforts to challenge the narratives and policies surrounding the COVID-19 pandemic, particularly focusing on issues of informed consent, governmental transparency, and accountability of pharmaceutical companies.